AstraZeneca Is Said to Have Explored Bristol Myers Merger
AstraZeneca has explored an acquisition of Bristol Myers Squibb, according to people familiar with the matter. It's unclear if discussions are ongoing or whether they will result in a transaction, the people cautioned. A representative for AstraZeneca declined to comment and Bristol Myers Squibb couldn't immediately be reached for comment on the talks. Bloomberg's Manuel Baigorri reports.
More from Australia
Argenica’s US stroke trial stalls as FDA demands rat brain study
Echo IQ shares sink 42% as FDA upholds rejection
Australian Vintage names new CFO, starting January 2027
ASIC warns on QUFC Exchange, removes 20+ websites
WA Government commits $4m to life sciences hub
Count Financial wins Federal Court appeal in class action over advisor commissions